Literature DB >> 6648785

Estimation of rate of growth of malignant brain tumors by computed tomography scanning.

T Yamashita, T Kuwabara.   

Abstract

The growth rate of malignant gliomas was estimated by serial computed tomography scanning. The actual tumor doubling time was determined by calculating the change in tumor volume on the scans. Eleven malignant gliomas were assessed by this method. The actual tumor doubling times of malignant gliomas ranged from 15.0 to 21.1 days, averaged 19.5 +/- 1.9 days, and showed no significant variation according to histopathologic differences. By determining the tumor doubling time in this manner, the growth rate of a tumor can be assessed. The efficacy of treatment and subsequent prognosis in malignant brain tumors can be predicted more accurately by estimation of the growth rate. The clinical application of the growth rate of malignant gliomas is presented.

Entities:  

Mesh:

Year:  1983        PMID: 6648785     DOI: 10.1016/0090-3019(83)90029-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  15 in total

Review 1.  Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm.

Authors:  Emmanuel Mandonnet; Johan Pallud; Olivier Clatz; Luc Taillandier; Ender Konukoglu; Hugues Duffau; Laurent Capelle
Journal:  Neurosurg Rev       Date:  2008-02-26       Impact factor: 3.042

2.  The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.

Authors:  S M Ekramullah; Y Saitoh; N Arita; T Ohnishi; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

Authors:  C J Vecht; C J Avezaat; W L van Putten; W M Eijkenboom; S Z Stefanko
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

4.  Impact of imaging measurements on response assessment in glioblastoma clinical trials.

Authors:  David A Reardon; Karla V Ballman; Jan C Buckner; Susan M Chang; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

5.  Modeling the growth dynamics of glioblastoma using magnetic resonance imaging.

Authors:  Chaitra Badve; Andrew E Sloan
Journal:  Neuro Oncol       Date:  2015-07-12       Impact factor: 12.300

6.  Growth dynamics of untreated glioblastomas in vivo.

Authors:  Anne Line Stensjøen; Ole Solheim; Kjell Arne Kvistad; Asta K Håberg; Øyvind Salvesen; Erik Magnus Berntsen
Journal:  Neuro Oncol       Date:  2015-03-10       Impact factor: 12.300

7.  Glucocorticoid receptors in glioblastoma multiforme: a new approach to antineoplastic glucocorticoid therapy.

Authors:  K Ellemann; L Christensen; F Gjerris; P Briand; C Kruse-Larsen
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

8.  A medulloblastoma showing an unusually long doubling time: reflection of its singular nature.

Authors:  Omer Doron; Jacob Zauberman; Ze'ev Feldman
Journal:  Childs Nerv Syst       Date:  2016-01-06       Impact factor: 1.475

9.  Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.

Authors:  J Jääskeläinen; E Laasonen; J Kärkkäinen; M Haltia; H Troupp
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

10.  Tumor cord and growth in human brain tumors based on mathematical morphology.

Authors:  Y Yoshii; K Narushima; K Tsuboi; Y Maki; K Sugiyama
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.